Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on rare diseases, has announced its participation in two upcoming investor conferences in September 2024. The company will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5 at 10:00 a.m. ET and the Cantor Global Healthcare Conference 2024 on September 17 at 1:55 p.m. ET, both in New York, NY.

Investors can access live audio webcasts of these presentations through the company's website. Amicus Therapeutics is dedicated to discovering, developing, and delivering novel high-quality medicines for people living with rare diseases. The company emphasizes its commitment to advancing a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases.

PRINCETON, N.J., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in September.

• Morgan Stanley 22^nd Annual Global Healthcare Conference in New York, NY, on Thursday, September 5, 2024, at 10:00 a.m. ET
• Cantor Global Healthcare Conference 2024 in New York, NY on Tuesday, September 17, 2024, at 1:55 p.m. ET

A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

When and where will Amicus Therapeutics (FOLD) present at investor conferences in September 2024?

Amicus Therapeutics will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, at 10:00 a.m. ET and the Cantor Global Healthcare Conference 2024 on September 17, 2024, at 1:55 p.m. ET. Both conferences will be held in New York, NY.

How can investors access Amicus Therapeutics' (FOLD) presentations at the September 2024 conferences?

Investors can access live audio webcasts of the presentations through the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

What is the main focus of Amicus Therapeutics (FOLD) as a biotechnology company?

Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare diseases.

What is Amicus Therapeutics' (FOLD) commitment regarding its pipeline for rare diseases?

Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases.